Literature DB >> 22847518

[Evaluation of time, attendance of medical staff, and resources during stereotactic radiotherapy/radiosurgery : QUIRO-DEGRO Trial].

A Zabel-du Bois1, S Milker-Zabel, M Henzel, W Popp, J Debus, H Sack, R Engenhart-Cabillic.   

Abstract

BACKGROUND: The German Society of Radiation Oncology ("Deutsche Gesellschaft für Radioonkologie", DEGRO) initiated a multicenter trial to develop and evaluate adequate modules to assert core processes and subprocesses in radiotherapy. The aim of this prospective evaluation was to methodical assess the required resources (technical equipment and medical staff) for stereotactic radiotherapy/radiosurgery.
MATERIAL AND METHODS: At two radiotherapy centers of excellence (University Hospitals of Heidelberg and Marburg/Giessen), the manpower and time required for the implementation of intra- and extracranial stereotactic radiotherapy was prospectively collected consistently over a 3-month period. The data were collected using specifically developed process acquisition tools and standard forms and were evaluated using specific process analysis tools.
RESULTS: For intracranial (extracranial) fractionated stereotactic radiotherapy (FSRT) and radiosurgery (RS), a total of 1,925 (270) and 199 (36) records, respectively, could be evaluated. The approximate time needed to customize the immobilization device was median 37 min (89 min) for FRST and 31 min (26 min) for RS, for the contrast enhanced planning studies 22 and 27 min (25 and 28 min), for physical treatment planning 122 and 59 min (187 and 27 min), for the first and routine radiotherapy sessions for FSRT 40 and 13 min (58 and 31 min), respectively. The median time needed for the RS session was 58 min (45 min). The corresponding minimal manpower needed was 2 technicians for customization of the immobilization device, 2.5 technicians and 1 consultant for the contrast-enhanced planning studies, 1 consultant, 0.5 resident and 0.67 medical physics expert (MPE) for physical treatment planning, as well as 1 consultant, 0.5 resident, and 2.5 technicians for the first radiotherapy treatment and 2.33 technicians for routine radiotherapy sessions.
CONCLUSION: For the first time, the resource requirements for a radiotherapy department for the maintenance, protection and optimization of operational readiness for the application of intra- and extracranial stereotactic radiotherapy was determined methodically.

Mesh:

Year:  2012        PMID: 22847518     DOI: 10.1007/s00066-012-0140-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  20 in total

1.  Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources.

Authors:  R Esco; A Palacios; J Pardo; A Biete; J A Carceller; C Veiras; G Vazquez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

2.  Linac-based radiosurgery or hypofractionated stereotactic radiotherapy in the treatment of large cerebral arteriovenous malformations.

Authors:  Angelika Zabel-du Bois; Stefanie Milker-Zabel; Peter Huber; Wolfgang Schlegel; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-10       Impact factor: 7.038

3.  Quality assurance control in the EORTC cooperative group of radiotherapy. 1. Assessment of radiotherapy staff and equipment. European Organization for Research and Treatment of Cancer.

Authors:  J C Horiot; K A Johansson; D G Gonzalez; E van der Schueren; W van den Bogaert; G Notter
Journal:  Radiother Oncol       Date:  1986-08       Impact factor: 6.280

Review 4.  The cost of radiation therapy.

Authors:  Nicolas Paul Ploquin; Peter Brian Dunscombe
Journal:  Radiother Oncol       Date:  2008-01-30       Impact factor: 6.280

5.  Stereotactic body radiotherapy for lung tumors at the pulmonary hilum.

Authors:  Yoshiko Oshiro; Takashi Aruga; Koji Tsuboi; Kan Marino; Ryusuke Hara; Yasushi Sanayama; Jun Itami
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

6.  Image guided respiratory gated hypofractionated Stereotactic Body Radiation Therapy (H-SBRT) for liver and lung tumors: Initial experience.

Authors:  R E Wurm; F Gum; S Erbel; L Schlenger; D Scheffler; D Agaoglu; R Schild; B Gebauer; P Rogalla; M Plotkin; K Ocran; V Budach
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

7.  Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer.

Authors:  Richard Holy; Marc Piroth; Michael Pinkawa; Michael J Eble
Journal:  Strahlenther Onkol       Date:  2011-03-21       Impact factor: 3.621

8.  Evaluation of time, attendance of medical staff, and resources during radiotherapy for head and neck cancer patients: the DEGRO-QUIRO trial.

Authors:  Wilfried Budach; Edwin Bölke; Rainer Fietkau; Andre Buchali; Thomas G Wendt; Wolfgang Popp; Christiane Matuschek; Horst Sack
Journal:  Strahlenther Onkol       Date:  2011-07-22       Impact factor: 3.621

9.  Profile of radiotherapy departments contributing to the Cooperative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.

Authors:  J Bernier; J C Horiot; H Bartelink; K A Johansson; L Cionini; D Gonzalèz Gonzalèz; H Hamers; W van den Bogaert
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-03-01       Impact factor: 7.038

10.  Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases.

Authors:  Peter Fritz; Hans-Jörg Kraus; Werner Mühlnickel; Udo Hammer; Wolfram Dölken; Walburga Engel-Riedel; Assad Chemaissani; Erich Stoelben
Journal:  Radiat Oncol       Date:  2006-08-20       Impact factor: 3.481

View more
  14 in total

1.  Evaluation of time, attendance of medical staff and resources for radiotherapy in pediatric and adolescent patients. The DEGRO-QUIRO trial.

Authors:  Angelika Zabel-du Bois; Stefanie Milker-Zabel; Frank Bruns; Hans Christiansen; Iris Ernst; Normann Willich; Wolfgang Popp; Jürgen Debus; Horst Sack
Journal:  Strahlenther Onkol       Date:  2014-04-01       Impact factor: 3.621

2.  Time management in radiation oncology: evaluation of time, attendance of medical staff, and resources during radiotherapy for prostate cancer: the DEGRO-QUIRO trial.

Authors:  L Keilholz; J Willner; H-J Thiel; N Zamboglou; H Sack; W Popp
Journal:  Strahlenther Onkol       Date:  2013-10-16       Impact factor: 3.621

3.  The QUIRO Study (assurance of quality and innovation in radiooncology): methodology, instruments and practices.

Authors:  J Dunst; N Willich; H Sack; R Engenhart-Cabillic; V Budach; W Popp
Journal:  Strahlenther Onkol       Date:  2014-01-11       Impact factor: 3.621

4.  Evaluation of time, attendance of medical staff, and resources during interstitial brachytherapy for prostate cancer : DEGRO-QUIRO trial.

Authors:  N Tselis; U Maurer; W Popp; H Sack; N Zamboglou
Journal:  Strahlenther Onkol       Date:  2014-02-07       Impact factor: 3.621

5.  [Personnel requirements of medical radiation physics in radiotherapy in comparison to the current guidelines "radiation protection in medicine" : Special consideration of intensity-modulated radiation therapy].

Authors:  H-K Leetz; H H Eipper; H Gfirtner; P Schneider; K Welker
Journal:  Strahlenther Onkol       Date:  2014-05-08       Impact factor: 3.621

6.  Protection of quality and innovation in radiation oncology: the prospective multicenter trial QUIRO of DEGRO: evaluation of time, attendance of medical staff, and resources during radiotherapy with tomotherapy.

Authors:  Cornelia Winkler; M N Duma; W Popp; H Sack; V Budach; M Molls; S Kampfer
Journal:  Strahlenther Onkol       Date:  2014-03-22       Impact factor: 3.621

7.  Time evaluation of image-guided radiotherapy in patients with spinal bone metastases. A single-center study.

Authors:  H Rief; D Habermehl; K Schubert; J Debus; S E Combs
Journal:  Strahlenther Onkol       Date:  2014-01-16       Impact factor: 3.621

8.  CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer : A prospective evaluation of 95 patients/118 lesions.

Authors:  B A Jereczek-Fossa; I Bossi-Zanetti; R Mauro; G Beltramo; L Fariselli; L C Bianchi; C Fodor; P Fossati; G Baroni; R Orecchia
Journal:  Strahlenther Onkol       Date:  2013-04-21       Impact factor: 3.621

9.  Evaluation of the time required for overhead tasks performed by physicians, medical physicists, and technicians in radiation oncology institutions: the DEGRO-QUIRO study.

Authors:  Cornelia Sack; Horst Sack; Normann Willich; Wolfgang Popp
Journal:  Strahlenther Onkol       Date:  2014-09-23       Impact factor: 3.621

10.  Protection of quality and innovation in radiation oncology: the prospective multicenter trial the German Society of Radiation Oncology (DEGRO-QUIRO study). Evaluation of time, attendance of medical staff, and resources during radiotherapy with IMRT.

Authors:  H Vorwerk; K Zink; R Schiller; V Budach; D Böhmer; S Kampfer; W Popp; H Sack; R Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2014-03-05       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.